Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating Medroxyprogesterone Acetate after injection of TV-46046 in healthy women of reproductive age; completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)
• TV-46046

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Contraception | Phase 1 | Status: COMPLETED | Results posted: 2024-02-26